AURKB and non-small cell lung carcinoma: Further analysis of AURKB through the GEPIA2 database revealed that high AURKB expression correlates with shorter overall survival (OS) and progression‐free survival (PFS), supporting its identification as a risk factor for NSCLC (Figure S5).